AAAAAA
Results: 1-25/36
Authors:
LU ZH
ZHANG RW
CARPENTER JT
DIASIO RB
Citation: Zh. Lu et al., DECREASED DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN A POPULATION OFPATIENTS WITH BREAST-CANCER - IMPLICATION FOR 5-FLUOROURACIL-BASED CHEMOTHERAPY, Clinical cancer research, 4(2), 1998, pp. 325-329
Authors:
LU ZH
ZHANG RW
CARPENTER JT
DIASIO RB
Citation: Zh. Lu et al., DECREASED DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN A POPULATION OFPATIENTS WITH BREAST-CANCER - IMPLICATION FOR 5-FLUOROURACIL-BASED CHEMOTHERAPY, Clinical cancer research, 4(2), 1998, pp. 325-329
Authors:
DIASIO RB
Citation: Rb. Diasio, IMPROVING 5-FU WITH A NOVEL DIHYDROPYRIMIDINE DEHYDROGENASE INACTIVATOR, Oncology, 12(3), 1998, pp. 51-56
Authors:
DIASIO RB
Citation: Rb. Diasio, THE ROLE OF DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) MODULATION IN 5-FU PHARMACOLOGY, Oncology, 12(10), 1998, pp. 23-27
Authors:
DIASIO RB
Citation: Rb. Diasio, SORIVUDINE AND 5-FLUOROURACIL - A CLINICALLY SIGNIFICANT DRUG-DRUG INTERACTION DUE TO INHIBITION OF DIHYDROPYRIMIDINE DEHYDROGENASE, British journal of clinical pharmacology, 46(1), 1998, pp. 1-4
Authors:
DIASIO RB
LU Z
ZHANG R
Citation: Rb. Diasio et al., DECREASED DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN BREAST-CANCER, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 2-2
Authors:
YAN J
SHAO L
WALSH GM
OMURA GA
SALEH M
DUVIC M
LING M
DIASIO RB
Citation: J. Yan et al., INITIAL MULTIPLE-DOSE PHARMACOKINETICS OF ORAL-ADMINISTRATION OF BCX-34, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 97-97
Authors:
JOHNSON MR
YAN JM
SHAO LN
ALBIN N
DIASIO RB
Citation: Mr. Johnson et al., SEMIAUTOMATED RADIOASSAY FOR DETERMINATION OF DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY - SCREENING CANCER-PATIENTS FOR DPD DEFICIENCY, A CONDITION ASSOCIATED WITH 5-FLUOROURACIL TOXICITY, Journal of chromatography B. Biomedical sciences and applications, 696(2), 1997, pp. 183-191
Authors:
YAN JM
LU ZH
WALSH GM
WHEELER RH
DIASIO RB
Citation: Jm. Yan et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF 9-(3-PYRIDYLMETHYL)-9-DEAZAGUANINE (BCX-34) IN BIOLOGICAL-FLUIDS, Journal of chromatography B. Biomedical sciences and applications, 690(1-2), 1997, pp. 295-303
Authors:
DIASIO RB
ZHANG RW
Citation: Rb. Diasio et Rw. Zhang, PHARMACOLOGY OF THERAPEUTIC OLIGONUCLEOTIDES, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(3), 1997, pp. 239-243
Authors:
JIANG WQ
LU ZH
HE YJ
DIASIO RB
Citation: Wq. Jiang et al., DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN HEPATOCELLULAR-CARCINOMA - IMPLICATION IN 5-FLUOROURACIL-BASED CHEMOTHERAPY, Clinical cancer research, 3(3), 1997, pp. 395-399
Authors:
YAN JM
TYRING SK
MCCRARY MM
LEE PC
HAWORTH S
RAYMOND R
OLSEN SJ
DIASIO RB
Citation: Jm. Yan et al., THE EFFECT OF SORIVUDINE ON DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN PATIENTS WITH ACUTE HERPES-ZOSTER, Clinical pharmacology and therapeutics, 61(5), 1997, pp. 563-573
Authors:
JOHNSON MR
WANG KS
TILLMANNS S
ALBIN N
DIASIO RB
Citation: Mr. Johnson et al., STRUCTURAL ORGANIZATION OF THE HUMAN DIHYDROPYRIMIDINE DEHYDROGENASE GENE, Cancer research, 57(9), 1997, pp. 1660-1663
Authors:
DIASIO RB
JOHNSON MR
ALBIN N
Citation: Rb. Diasio et al., MUTATIONS AT CODON-974 OF THE DPYD GENE ARE A RARE EVENT, British Journal of Cancer, 76(8), 1997, pp. 1113-1113
Authors:
TAKIMOTO CH
LU ZH
ZHANG RW
LIANG MD
LARSON LV
CANTILENA LR
GREM JL
ALLEGRA CJ
DIASIO RB
CHU E
Citation: Ch. Takimoto et al., SEVERE NEUROTOXICITY FOLLOWING 5-FLUOROURACIL-BASED CHEMOTHERAPY IN APATIENT WITH DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY, Clinical cancer research, 2(3), 1996, pp. 477-481
Authors:
ALBIN N
JOHNSON MR
DIASIO RB
Citation: N. Albin et al., CDNA CLONING OF BOVINE LIVER DIHYDROPYRIMIDINE DEHYDROGENASE, DNA sequence, 6(4), 1996, pp. 243-250
Authors:
SALEH MN
DIASIO RB
SAMS WM
WHEELER RH
GREGG X
OMURA GA
WALSH GM
Citation: Mn. Saleh et al., PHASE-I EVALUATION OF ORAL BCX-34 (PELDESINE) IN CUTANEOUS T-CELL LYMPHOMA (CTCL), Blood, 88(10), 1996, pp. 2277-2277
Authors:
ZHAO H
LU Z
DIASIO RB
AGRAWAL S
ZHANG R
Citation: H. Zhao et al., BILIARY-EXCRETION OF OLIGONUCLEOTIDES - PREVIOUSLY UNRECOGNIZED PATHWAY IN METABOLISM OF ANTISENSE OLIGONUCLEOTIDES, The FASEB journal, 9(3), 1995, pp. 410-410
Authors:
GANDARA DR
NAHHAS WA
ADELSON MD
LICHTMAN SM
PODCZASKI ES
YANOVICH S
HOMESLEY HD
BRALY P
RITCH PS
WEISBERG SR
WILLIAMS L
DIASIO RB
PEREZ EA
KARP D
REICH SD
MCCARROLL K
HOFF JV
Citation: Dr. Gandara et al., RANDOMIZED PLACEBO-CONTROLLED MULTICENTER EVALUATION OF DIETHYLDITHIOCARBAMATE FOR CHEMOPROTECTION AGAINST CISPLATIN-INDUCED TOXICITIES, Journal of clinical oncology, 13(2), 1995, pp. 490-496
Authors:
LU ZH
ZHANG RW
DIASIO RB
Citation: Zh. Lu et al., POPULATION CHARACTERISTICS OF HEPATIC DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY, A KEY METABOLIC ENZYME IN 5-FLUOROURACIL CHEMOTHERAPY, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 512-522
Authors:
ZHANG RW
YAN JM
SHAHINIAN H
AMIN G
LU ZH
LIU TP
SAAG MS
JIANG ZW
TEMSAMANI J
MARTIN RR
SCHECHTER PJ
AGRAWAL S
DIASIO RB
Citation: Rw. Zhang et al., PHARMACOKINETICS OF AN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) IN HIV-INFECTED SUBJECTS, Clinical pharmacology and therapeutics, 58(1), 1995, pp. 44-53
IN-VIVO STABILITY AND DISPOSITION OF A SELF-STABILIZED OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE IN RATS
Authors:
ZHANG RW
LU ZH
ZHANG XS
ZHAO H
DIASIO RB
LIU TP
JIANG ZW
AGRAWAL S
Citation: Rw. Zhang et al., IN-VIVO STABILITY AND DISPOSITION OF A SELF-STABILIZED OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE IN RATS, Clinical chemistry, 41(6), 1995, pp. 836-843
Authors:
ZHANG RW
LU ZH
ZHAO H
ZHANG XS
DIASIO RB
HABUS I
JIANG ZW
IYER RP
YU D
AGRAWAL S
Citation: Rw. Zhang et al., IN-VIVO STABILITY, DISPOSITION AND METABOLISM OF A HYBRID OLIGONUCLEOTIDE PHOSPHOROTHIOATE IN RATS, Biochemical pharmacology, 50(4), 1995, pp. 545-556
Authors:
AGRAWAL S
ZHANG XS
LU ZH
ZHAO H
TAMBURIN JM
YAN YM
CAI HY
DIASIO RB
HABUS I
JIANG ZW
IYER RP
YU D
ZHANG RW
Citation: S. Agrawal et al., ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION, Biochemical pharmacology, 50(4), 1995, pp. 571-576
Authors:
ZHANG RW
DIASIO RB
LU ZH
LIU TP
JIANG ZW
GALBRAITH WM
AGRAWAL S
Citation: Rw. Zhang et al., PHARMACOKINETICS AND TISSUE DISTRIBUTION IN RATS OF AN OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) DEVELOPED AS A THERAPEUTIC AGENT FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Biochemical pharmacology, 49(7), 1995, pp. 929-939